|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-5-25
|
|
pubmed:abstractText |
Cancer patients with fever and neutropenia currently are assessed on clinical grounds only. The current study prospectively evaluated the efficacy of baseline procalcitonin (PCT) in the detection of bacteremia and in the prediction of outcome in patients with solid tumors and febrile neutropenia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:Cortés-FunesHernánH,
pubmed-author:DuránIgnacioI,
pubmed-author:García-VelascoAdelaidaA,
pubmed-author:González-BillalabeitiaEnriqueE,
pubmed-author:HernándezRosarioR,
pubmed-author:HernandoSusanaS,
pubmed-author:JimenoAntonioA,
pubmed-author:López-MartínAnaA,
pubmed-author:Paz-AresLuisL,
pubmed-author:RoblesLuisL,
pubmed-author:Sánchez-MuñozAlfonsoA,
pubmed-author:del ValOlgaO
|
|
pubmed:copyrightInfo |
Copyright 2004 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
100
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2462-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15160353-Adult,
pubmed-meshheading:15160353-Aged,
pubmed-meshheading:15160353-Biological Markers,
pubmed-meshheading:15160353-Calcitonin,
pubmed-meshheading:15160353-Diagnosis, Differential,
pubmed-meshheading:15160353-Female,
pubmed-meshheading:15160353-Fever,
pubmed-meshheading:15160353-Humans,
pubmed-meshheading:15160353-Male,
pubmed-meshheading:15160353-Middle Aged,
pubmed-meshheading:15160353-Neoplasms,
pubmed-meshheading:15160353-Neutropenia,
pubmed-meshheading:15160353-Prognosis,
pubmed-meshheading:15160353-Prospective Studies,
pubmed-meshheading:15160353-Protein Precursors,
pubmed-meshheading:15160353-Risk Factors,
pubmed-meshheading:15160353-Sensitivity and Specificity,
pubmed-meshheading:15160353-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
|
|
pubmed:affiliation |
Division of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article
|
